Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:3472-3479
Published online before print November 22, 2004, doi: 10.1161/01.CIR.0000148368.79202.F1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/22/3472    most recent
01.CIR.0000148368.79202.F1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, J.
Right arrow Articles by Hajjar, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, J.
Right arrow Articles by Hajjar, D. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Statins
Related Collections
Right arrow Gene regulation
Right arrow Lipid and lipoprotein metabolism

(Circulation. 2004;110:3472-3479.)
© 2004 American Heart Association, Inc.


Molecular Cardiology

Functional Interplay Between the Macrophage Scavenger Receptor Class B Type I and Pitavastatin (NK-104)

Jihong Han, PhD; Michael Parsons, MD; Xiaoye Zhou, MD; Andrew C. Nicholson, DVM, PhD; Antonio M. Gotto, Jr, MD, DPhil; David P. Hajjar, PhD

From the Center of Vascular Biology and Department of Pathology (J.H., X.Z., A.C.N., D.P.H.) and the Department of Medicine (M.P., A.M.G.), Weill Medical College of Cornell University, New York, NY.

Correspondence to Jihong Han, PhD, Center of Vascular Biology/Department of Pathology, Weill Medical College of Cornell University, 1300 York Ave, New York, NY 10021. E-mail jhan{at}med.cornell.edu

Received February 2, 2004; de novo received March 25, 2004; revision received September 3, 2004; accepted September 14, 2004.

Background— Scavenger receptor class B type I (SR-BI), a receptor for high-density lipoprotein (HDL), plays an important role in the bidirectional cholesterol exchange between cells and HDL particles and the atherosclerotic lesion development. Enhancement of SR-BI expression significantly reduces, whereas lack of SR-BI expression accelerates, the atherosclerotic lesion development in proatherogenic mice. Statins, a class of inhibitors for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, significantly suppress de novo cholesterol synthesis and reduce the incidence of coronary heart disease. Statins also display multiple pleiotropic effects independently of cholesterol synthesis in the vascular cells. Here, we investigated the effects of pitavastatin (NK-104), a newly synthesized statin, on macrophage SR-BI expression.

Methods and Results— We found that pitavastatin significantly increased SR-BI mRNA and protein expression in a macrophage cell line in a concentration- and time-dependent manner. It also increased SR-BI expression in both mouse peritoneal and human monocyte-derived macrophages. Associated with increased SR-BI expression, pitavastatin enhanced macrophage HDL binding, uptake of [14C]cholesteryl oleate/HDL, and efflux of [3H]cholesterol to HDL. Pitavastatin abolished the inhibition of macrophage SR-BI expression by cholesterol biosynthetic intermediates. It also restored SR-BI expression inhibited by lipopolysaccharide and tumor necrosis factor-{alpha} through its inactivation of the transcription factor nuclear factor-{kappa}B.

Conclusions— Our data demonstrate that pitavastatin can stimulate macrophage SR-BI expression by reduction of cholesterol biosynthetic intermediates and antiinflammatory action and suggest additional pleiotropic effects of statins by which they may reduce the incidence of coronary heart disease.


Key Words: statins • macrophages • scavenger receptors • lipoproteins




This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Kimura, C. Mogi, H. Tomura, A. Kuwabara, D.-S. Im, K. Sato, H. Kurose, M. Murakami, and F. Okajima
Induction of Scavenger Receptor Class B Type I Is Critical for Simvastatin Enhancement of High-Density Lipoprotein-Induced Anti-Inflammatory Actions in Endothelial Cells
J. Immunol., November 15, 2008; 181(10): 7332 - 7340.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Zhou, W. He, Z. Huang, A. M. Gotto Jr., D. P. Hajjar, and J. Han
Genetic Deletion of Low Density Lipoprotein Receptor Impairs Sterol-induced Mouse Macrophage ABCA1 Expression: A NEW SREBP1-DEPENDENT MECHANISM
J. Biol. Chem., January 25, 2008; 283(4): 2129 - 2138.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Tsuchiya, T. Yoshimoto, Y. Hirono, T. Tateno, T. Sugiyama, and Y. Hirata
Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-{kappa}B-dependent pathway in rat preadipocytes
Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E771 - E778.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Argmann, J. Y. Edwards, C. G. Sawyez, C. H. O'Neil, R. A. Hegele, J. G. Pickering, and M. W. Huff
Regulation of Macrophage Cholesterol Efflux through Hydroxymethylglutaryl-CoA Reductase Inhibition: A ROLE FOR RhoA IN ABCA1-MEDIATED CHOLESTEROL EFFLUX
J. Biol. Chem., June 10, 2005; 280(23): 22212 - 22221.
[Abstract] [Full Text] [PDF]